Lung Disease News and Research

RSS
SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

Researchers identify common genetic connection in lung conditions

Researchers identify common genetic connection in lung conditions

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

Study: Federal Agencies underestimate e-cigarette explosion and burn injuries

Study: Federal Agencies underestimate e-cigarette explosion and burn injuries

Study finds disease-causing mutation in French-Canadians

Study finds disease-causing mutation in French-Canadians

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Medicare eases readmission penalties against safety-net hospitals

Medicare eases readmission penalties against safety-net hospitals

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer

Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Boehringer Ingelheim announces study results of COPD patients treated with Spiolto Respimat

Boehringer Ingelheim announces study results of COPD patients treated with Spiolto Respimat

New wearable ultrasound device tracks blood pressure deep inside the body

New wearable ultrasound device tracks blood pressure deep inside the body

Deaths from inhalation of wildfire smoke in the U.S. could double by 2100

Deaths from inhalation of wildfire smoke in the U.S. could double by 2100